SEC Form 4 · accession 0001209191-18-052906
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karin Eastham
Director
Period of report
Sep 27, 2018
Accepted (ET)
Oct 1, 2018 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 27, 2018 | A | 8,500 | $0.00 | A | 8,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $60.91 | Sep 27, 2018 | A | 17,000 | A | — | Sep 26, 2026 | Common Stock | 17,000 | 17,000 | D |
Explanation of responses
- F1This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
- F2This restricted stock unit award vests over three years in equal annual installments beginning on September 27, 2018.
- F3This stock option vests in equal monthly installments over the three-year period beginning on September 30, 2018.